Literature DB >> 7702382

Prevention of cross infection during outpatient spirometry.

J Marchant1, A Bush.   

Abstract

Lung function apparatus may be a source of cross infection in patients with cystic fibrosis and may be prevented using a 'bag in bottle' system. As this system has never been validated in children the flow volume loops performed using a Vitalograph Compact in the usual way were compared with results obtained blowing into the bag and bottle system, in random order, in 20 children with asthma (age 8-15 years). Three reproducible flow volume loops were recorded for each apparatus. There was no order effect. Mean (SE) results for forced expiratory volume in one second, forced vital capacity (FVC), peak expiratory flow rate, and maximum expiratory flow at between 75% and 25% of FVC showed respectively that the bag in bottle results were significantly greater than those obtained blowing directly into the spirometer by 90 (17) ml, 12.7 (5.1) l/min, 130 (60) ml/min. Although statistically significant, these differences are within the previously described coefficients of variation for children with cystic fibrosis and are of doubtful clinical relevance. It is concluded that the bag in bottle system does not introduce any important systematic error. It potentially offers absolute protection from cross infection.

Entities:  

Mesh:

Year:  1995        PMID: 7702382      PMCID: PMC1510996          DOI: 10.1136/adc.72.2.156

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  8 in total

1.  Pseudomonas cepacia in inpatients with cystic fibrosis.

Authors:  J W Nelson; C J Doherty; P H Brown; A P Greening; M E Kaufmann; J R Govan
Journal:  Lancet       Date:  1991-12-14       Impact factor: 79.321

2.  Pseudomonas cepacia in cystic fibrosis.

Authors:  D E Stableforth; D L Smith
Journal:  Thorax       Date:  1994-07       Impact factor: 9.139

3.  Pseudomonas cepacia in cystic fibrosis: transmissibility and its implications.

Authors:  S Walters; E G Smith
Journal:  Lancet       Date:  1993-07-03       Impact factor: 79.321

4.  Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis.

Authors:  J R Govan; P H Brown; J Maddison; C J Doherty; J W Nelson; M Dodd; A P Greening; A K Webb
Journal:  Lancet       Date:  1993-07-03       Impact factor: 79.321

5.  Flow volume curves in children with cystic fibrosis--a possible risk of cross-infection?

Authors:  J L Marchant; S A Little; A Bush
Journal:  Respir Med       Date:  1994-03       Impact factor: 3.415

6.  Serial changes in pulmonary functions in children hospitalized with cystic fibrosis.

Authors:  G J Redding; R Restuccia; E K Cotton; J G Brooks
Journal:  Am Rev Respir Dis       Date:  1982-07

7.  Lung function testing and AIDS.

Authors:  D M Denison; D S Cramer; P J Hanson
Journal:  Respir Med       Date:  1989-03       Impact factor: 3.415

Review 8.  Management of asthma: a consensus statement.

Authors:  J O Warner; M Götz; L I Landau; H Levison; A D Milner; S Pedersen; M Silverman
Journal:  Arch Dis Child       Date:  1989-07       Impact factor: 3.791

  8 in total
  1 in total

1.  The practical application and interpretation of simple lung function tests in cystic fibrosis.

Authors:  P L Brand; C K van der Ent
Journal:  J R Soc Med       Date:  1999       Impact factor: 18.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.